PRD Therapeutics, Inc. was started as a drug discovery startup from Kitasato University School of Pharmacy.
PRD Therapeutics is a drug discovery startup developing novel regulators of lipid metabolism that are effective in rare and lifestyle diseases caused by dyslipidemia. Our development drugs originated from a group of our proprietary naturally occurring compounds are the world’s first and only SOAT2 selective inhibitors. By developing our oral medicines, we will bring smiles to patients and their families around the world through our medicines that enable reduction of patent burden.